Nevertheless, given the poor prognosis and high relapse rate, patients with NUP98r leukemia may benefit from FLT3 inhibitors, BCL2 inhibitors, and CDK4/6 inhibitors, as well as hematopoietic stem cell transplantation.6,21,22. The gene discussed is BCL2; the disease is leukemia.